tiprankstipranks
ImmuPharma PLC (GB:IMM)
LSE:IMM
Holding GB:IMM?
Track your performance easily

ImmuPharma (IMM) Cash flow

14 Followers

ImmuPharma Cash Flow

GB:IMM's free cash flow for Q2 2022 was £―. For the 2022 fiscal year, GB:IMM's free cash flow was decreased by £2.38M and operating cash flow was £―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
-£ -2.35M£ -4.83M£ -3.33M£ -4.22M£ -4.72M
Investing Cash Flow
-£ -77.42K£ -50.28K£ -569.20K£ -101.37K£ -2.09M
Financing Cash Flow
-£ 1.55M£ 702.05K£ 8.37M£ 325.71K£ 9.15M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-£ 667.81K£ 1.65M£ 5.86M£ 1.36M£ 4.91M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-£ 2.35M£ 3.55M£ 8.00M£ 2.66M£ 10.00M
Issuance Of Debt
--£ -722.98K£ 1.32M£ -89.22K£ -138.88K
Repayment Of Debt
--£ -722.98K£ -836.61K£ -89.22K£ -138.88K
Free Cash Flow
-£ -2.45M£ -4.83M£ -3.33M£ -4.22M£ -4.72M
Domestic Sales
------
Foreign Sales
------
Currency in GBP

ImmuPharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis